Tocqueville Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.5M | Buy |
219,220
+15,490
| +8% | +$1.22M | 0.24% | 115 |
|
|
2025
Q4 | $16.1M | Buy |
203,730
+10,685
| +6% | +$805K | 0.24% | 119 |
|
|
2025
Q3 | $12.6M | Buy |
193,045
+5,700
| +3% | +$278K | 0.18% | 144 |
|
|
2025
Q2 | $7.4M | Sell |
187,345
-50
| -0% | -$1.64K | 0.11% | 179 |
|
|
2025
Q1 | $5.65M | Sell |
187,395
-164,745
| -47% | -$5.4M | 0.09% | 173 |
|
|
2024
Q4 | $12.3M | Sell |
352,140
-54,730
| -13% | -$2.05M | 0.19% | 119 |
|
|
2024
Q3 | $16.3M | Buy |
406,870
+181,800
| +81% | +$8.46M | 0.26% | 104 |
|
|
2024
Q2 | $10.7M | Buy |
225,070
+65,690
| +41% | +$2.69M | 0.18% | 131 |
|
|
2024
Q1 | $6.91M | Sell |
159,380
-400
| -0.3% | -$19.1K | 0.11% | 156 |
|
|
2023
Q4 | $8.08M | Sell |
159,780
-1,950
| -1% | -$93.4K | 0.15% | 144 |
|
|
2023
Q3 | $7.34M | Sell |
161,730
-750
| -0.5% | -$30.9K | 0.14% | 146 |
|
|
2023
Q2 | $6.67M | Hold |
162,480
| – | – | 0.12% | 158 |
|
|
2023
Q1 | $5.81M | Buy |
162,480
+911
| +0.6% | +$34.2K | 0.11% | 171 |
|
|
2022
Q4 | $6.1M | Sell |
161,569
-825
| -0.5% | -$34.7K | 0.12% | 171 |
|
|
2022
Q3 | $7.18M | Sell |
162,394
-211
| -0.1% | -$8.89K | 0.15% | 145 |
|
|
2022
Q2 | $6.02M | Sell |
162,605
-4,900
| -3% | -$185K | 0.11% | 182 |
|
|
2022
Q1 | $6.2M | Sell |
167,505
-2,900
| -2% | -$94.9K | 0.09% | 202 |
|
|
2021
Q4 | $5.18M | Buy |
170,405
+1,875
| +1% | +$59K | 0.07% | 243 |
|
|
2021
Q3 | $5.65M | Sell |
168,530
-3,670
| -2% | -$138K | 0.08% | 228 |
|
|
2021
Q2 | $6.87M | Sell |
172,200
-73,292
| -30% | -$2.87M | 0.1% | 220 |
|
|
2021
Q1 | $11M | Sell |
245,492
-25,405
| -9% | -$1.42M | 0.17% | 140 |
|
|
2020
Q4 | $15.3M | Sell |
270,897
-4,935
| -2% | -$246K | 0.26% | 100 |
|
|
2020
Q3 | $13.1M | Sell |
275,832
-2,980
| -1% | -$166K | 0.25% | 92 |
|
|
2020
Q2 | $16.4M | Sell |
278,812
-5,830
| -2% | -$324K | 0.34% | 68 |
|
|
2020
Q1 | $13.5M | Sell |
284,642
-117,155
| -29% | -$6.53M | 0.33% | 73 |
|
|
2019
Q4 | $24.3M | Sell |
401,797
-7,510
| -2% | -$447K | 0.36% | 76 |
|
|
2019
Q3 | $24.5M | Sell |
409,307
-37,008
| -8% | -$2.41M | 0.33% | 81 |
|
|
2019
Q2 | $28.7M | Sell |
446,315
-4,479
| -1% | -$317K | 0.37% | 76 |
|
|
2019
Q1 | $36.6M | Sell |
450,794
-86,029
| -16% | -$5.55M | 0.49% | 59 |
|
|
2018
Q4 | $29M | Sell |
536,823
-50,839
| -9% | -$2.59M | 0.43% | 68 |
|
|
2018
Q3 | $30.3M | Sell |
587,662
-2,387
| -0.4% | -$112K | 0.38% | 79 |
|
|
2018
Q2 | $24.6M | Sell |
590,049
-1,784
| -0.3% | -$79.1K | 0.31% | 94 |
|
|
2018
Q1 | $26.1M | Sell |
591,833
-249,891
| -30% | -$12.7M | 0.33% | 95 |
|
|
2017
Q4 | $42.3M | Buy |
841,724
+136,317
| +19% | +$7.48M | 0.48% | 62 |
|
|
2017
Q3 | $35.8M | Sell |
705,407
-20,220
| -3% | -$1.06M | 0.41% | 69 |
|
|
2017
Q2 | $36.9M | Sell |
725,627
-51,662
| -7% | -$2.41M | 0.44% | 61 |
|
|
2017
Q1 | $31.2M | Sell |
777,289
-45,221
| -5% | -$2.03M | 0.38% | 69 |
|
|
2016
Q4 | $39.3M | Sell |
822,510
-315,039
| -28% | -$12.5M | 0.5% | 50 |
|
|
2016
Q3 | $41.7M | Sell |
1,137,549
-188,571
| -14% | -$5.9M | 0.5% | 46 |
|
|
2016
Q2 | $30.9M | Buy |
1,326,120
+238,566
| +22% | +$7.7M | 0.37% | 65 |
|
|
2016
Q1 | $44M | Sell |
1,087,554
-23,911
| -2% | -$971K | 0.58% | 46 |
|
|
2015
Q4 | $68.8M | Sell |
1,111,465
-67,163
| -6% | -$3.62M | 0.93% | 21 |
|
|
2015
Q3 | $47.6M | Sell |
1,178,628
-47,843
| -4% | -$2.48M | 0.64% | 32 |
|
|
2015
Q2 | $70.6M | Sell |
1,226,471
-22,143
| -2% | -$1.41M | 0.83% | 18 |
|
|
2015
Q1 | $79.5M | Sell |
1,248,614
-218,318
| -15% | -$14.8M | 0.93% | 14 |
|
|
2014
Q4 | $90.6M | Sell |
1,466,932
-365,177
| -20% | -$18M | 0.97% | 10 |
|
|
2014
Q3 | $71.1M | Sell |
1,832,109
-30,794
| -2% | -$1.09M | 0.79% | 27 |
|
|
2014
Q2 | $64.2M | Buy |
1,862,903
+601,200
| +48% | +$18.9M | 0.62% | 37 |
|
|
2014
Q1 | $54.5M | Sell |
1,261,703
-398,181
| -24% | -$19.3M | 0.72% | 36 |
|
|
2013
Q4 | $66.1M | Buy |
1,659,884
+325
| +0% | +$11.6K | 0.89% | 21 |
|
|
2013
Q3 | $62.3M | Sell |
1,659,559
-282,194
| -15% | -$8.43M | 0.78% | 25 |
|
|
2013
Q2 | $52.2M | Buy |
+1,941,753
| New | +$41.3M | 0.71% | 32 |
|
Other funds holding IONS
VPM
VCM
Tocqueville Asset Management's IONS Position: Q1 2026 in Review
Tocqueville Asset Management increased its Ionis Pharmaceuticals (IONS) stake by 7.6% in Q1 2026, buying an estimated $1.22M and bringing the position to 219,220 shares worth $16.5M. The position accounts for 0.24% of the portfolio, ranked #115.
Tocqueville Asset Management first reported a position in IONS in Q2 2013 and has held it in 52 quarters since. The position peaked at $90.6M in Q4 2014. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Tocqueville Asset Management held 219,220 shares of Ionis Pharmaceuticals worth $16.5M as of Q1 2026.
- Tocqueville Asset Management bought 15,490 Ionis Pharmaceuticals shares in Q1 2026, an estimated $1.22M.
- Ionis Pharmaceuticals made up 0.24% of Tocqueville Asset Management's portfolio in Q1 2026, its #115 holding.
- Tocqueville Asset Management first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Tocqueville Asset Management's Ionis Pharmaceuticals position peaked at $90.6M in Q4 2014.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Tocqueville Asset Management's 13F filing for Q1 2026, filed 12 May 2026.